Načítá se...
大剂量地塞米松联合小剂量利妥昔单抗作为二线方案治疗65例原发免疫性血小板减少症患者的临床观察
OBJECTIVE: To observe the efficacy of high-dose dexamethasone in combination with low-dose rituximab as a second-line treatment for patients with immune thrombocytopenia (ITP). METHODS: 65 patients with ITP, previously by conventional dose of glucocorticoids, received high-dose dexamethasone in comb...
Uloženo v:
| Vydáno v: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial office of Chinese Journal of Hematology
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342512/ https://ncbi.nlm.nih.gov/pubmed/25854463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.03.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|